IHL - #Covid-19 Trials involving Hydroxychloriquine with CBD are about to Start (hence the interest this week imo)
Trials are being conducted in Taiwan with collaboration with https://www.eurofins.com/
Impression investigating IHL-675A for potential treatment of sepsis associated ARDS, leading cause of mortality from COVID-19 and other infections
- Forums
- ASX - Day Trading
- Morning trading May 27
Morning trading May 27, page-506
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
NEWS
Antler Copper Project hits major permitting milestone – air quality permit advances to final review